发明名称 MYELOPEROXIDASE, A RISK INDICATOR FOR CARDIOVASCULAR DISEASE
摘要 Diagnostic tests for characterizing an individual's risk of developing or having a cardiovascular disease. In one embodiment the present diagnostic test comprises determining the level of myeloperoxidase (MPO) activity in a bodily sample obtained from the individual or test subject. In another embodiment, the diagnostic test comprises determining the level of MPO mass in a bodily sample obtained from the test subject. In another embodiment, the diagnostic test comprises determining the level of one or more select MPO-generated oxidation products in a bodily sample obtained from the test subject. The select MPO-generated oxidation products are dityrosine, nitrotyrosine, methionine sulphoxide or an MPO-generated lipid peroxidation products. Levels of MPO activity, MPO mass, or the select MPO-generated oxidation product in bodily samples from the test subject are then compared to a predetermined value that is derived from measurements of MPO activity, MPO mass, or the select MPO-generated oxidation product in comparable bodily samples obtained from the general population or a select population of human subjects. Such comparison characterizes the test subject's risk of developing CVD.
申请公布号 US2008009020(A1) 申请公布日期 2008.01.10
申请号 US20070753799 申请日期 2007.05.25
申请人 THE CLEVELAND CLINIC FOUNDATION 发明人 HAZEN STANLEY;ZHANG RENLIANG
分类号 G01N33/573;C12Q1/28 主分类号 G01N33/573
代理机构 代理人
主权项
地址